A comprehensive drug development strategy that starts with extensive screening of potential targeting peptides to identify prototype small-molecule drugs has produced two that target the EGFR and VEGFR pathways in novel ways.
New strategy develops two prototype drugs against cancer, retinal diseases
March 14th, 2010 by Newspublichealth.com
Leave a Reply
Sorry, no posts matched your criteria.